Theses / Dissertations >
College of Health Sciences >
Please use this identifier to cite or link to this item:
|Title: ||Historical epidemiology of hepatitis C virus in select countries—volume 4|
|Authors: ||Phillips, Richard O.|
Kaliaskarova, K. S.
ghazzawi, I. Al
Himatt, S. M.
|Keywords: ||diagnosis, disease burden, epidemiology, HCV, hepatitis C, historical, incidence, mortality, prevalence, treatment|
|Issue Date: ||Jul-2017|
|Publisher: ||John Wiley & Sons Ltd.|
|Citation: ||J Viral Hepat. 2017;24(Suppl. 2):8–24.|
|Abstract: ||Due to the introduction of newer, more efficacious treatment options, there is a pressing
need for policy makers and public health officials to develop or adapt national
hepatitis C virus (HCV) control strategies to the changing epidemiological landscape.
To do so, detailed, country-specific
data are needed to characterize the burden of
chronic HCV infection. In this study of 17 countries, a literature review of published
and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution,
liver transplants and diagnosis and treatment rates was conducted, and inputs
were validated by expert consensus in each country. Viraemic prevalence in this study
ranged from 0.2% in Hong Kong to 2.4% in Taiwan, while the largest viraemic populations
were in Nigeria (2 597 000 cases) and Taiwan (569 000 cases). Diagnosis, treatment
and liver transplant rates varied widely across the countries included in this
analysis, as did the availability of reliable data. Addressing data gaps will be critical for
the development of future strategies to manage and minimize the disease burden of
|Description: ||An article published by John Wiley & Sons Ltd.and available at DOI: 10.1111/jvh.12762
SUPPLEMENT A R T|
|Appears in Collections:||College of Health Sciences|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.